Mucaltin pills dispersible 50mg, 20pcs

Composition

Active ingredient: marshmallow herb extract (mukaltin) – 50.0 mg;excipients: calcium phosphate 2-substituted anhydrous (calcium hydrogen phosphate anhydrous) – 219,03 mg crospovidone (crospovidon CE) – 102,82 mg, tartaric acid – 42,40 mg, black currant flavors* to 5.51 mg, calcium stearate – to 4.24 mg* consisting of flavour: natural flavouring substance, maltodextrin is 62.5%, gum Arabic (E 414) and 26.5%, triacetin (E 1518) is 6.5%.

Pharmacological properties

Pharmacotherapeutic group: expectorant plant origin

ATX Code: K 05 SA

Pharmacological properties

Mucaltin is a mixture of polysaccharides from the herb marshmallow officinalis, has expectorant properties. Due to reflex stimulation, it increases the activity of the ciliated epithelium and peristalsis of the respiratory bronchioles in combination with increased secretion of the bronchial glands.

Pharmacokinetics

No data available.

Indications

Acute and chronic diseases of the respiratory tract, accompanied by cough and the formation of difficult-to-separate sputum of increased viscosity (including tracheobronchitis, obstructive bronchitis, bronchiectasis, pneumonia) – as part of complex therapy.

Use during pregnancy and lactation

The use of the drug during pregnancy and lactation is possible on the recommendation of a doctor.

Contraindications

Hypersensitivity to the components of the drug, peptic ulcer of the stomach and duodenum, children under 12 years of age.

Side effects

Allergic reactions are possible, rarely dyspeptic phenomena. If you experience any of the side effects listed in the instructions or they get worse, or you notice any other side effects not listed in the instructions, tell your doctor.

Interaction

Mukaltin can be administered simultaneously with other medications used in the treatment of bronchopulmonary diseases.

Mucaltin should not be used concomitantly with codeine-containing medications and other antitussive medications, as this makes it difficult to cough up thin sputum.

If you are using the above or other medications (including over-the-counter medications), please consult your doctor before using Mukaltin.

How to take, course of use and dosage

Inside.

Adults and children over 12 years of age: 1-2 tablets 2-3 times a day before meals.

You can dissolve a single dose (1-2 tablets) in 1/3 cup of warm water.

The course of treatment is on average 7-14 days.

If there is no improvement during the treatment period, or if the symptoms worsen or new symptoms appear, you should consult your doctor. Use the drug only according to the indications, the method of use and in the doses indicated in the instructions.

Overdose

So far, no overdose cases have been reported.

Description

Round, biconvex tablets from light gray to brownish-gray color with inclusions of lighter and darker color, with a characteristic smell of currant.

Special instructions

Influence on the ability to drive vehicles and mechanisms

The use of the drug does not affect the ability to perform potentially dangerous activities that require increased concentration of attention and speed of psychomotor reactions (driving vehicles, working with moving mechanisms, working as a dispatcher, operator).

Form of production

Dispersible tablets,50 mg.

10 tablets in a contour cell package made of imported PVC film/PVDC and aluminum foil printed varnished.

1,2,3,4,5 contour cell packages together with the instructions for use are placed in a pack of cardboard.

Storage conditions

At a temperature not exceeding 25 °C. Keep out of reach of children.

Shelf

life is 2 years. Do not use after the expiration date.

Active ingredient

Marshmallow Medicinal Herb Extract

Dosage form

tablets soluble